Design Therapeutics, Inc. DSGN Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -30.7%-11.6pp | -19.1%+3.0pp | -22.1%-4.3pp | -17.8%— | |
| Return on invested capital | -37.9%-12.0pp | -25.9%+1.8pp | -27.7%+6.8pp | -34.5%— | |
| Efficiency | |||||
| Asset turnover | 0×— | 0×— | —— | —— | |
| Liquidity | |||||
| Current ratio | 17.1×-12.2× | 29.3×-0.3× | 29.6×-1.5× | 31.1×-41.9× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $3.71-13.4% | $4.28-13.7% | $4.96-15.6% | $5.88-29.4% | |
| Valuation | |||||
| Market capitalization | $860.66M+305% | $349.35M+135% | $148.35M-74.1% | $573.17M-51.8% | |
| Price / book | 3.9×+3.0× | 1.4×+0.9× | 0.5×-1.2× | 1.8×-1.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Design Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Design Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.